Pneumologie

PD Dr. med. Macé Schuurmans

Chefarzt
Pneumologie
Leiter Lungentumorzentrum

Originalarbeiten

  1. Jungo C, Russmann S, Benden C, Schuurmans MM.
    Use of oseltamivir in lung transplant recipients with suspected or proven influenza infection: a 1-year observational study of outcomes and safety.
    Antivir Ther. 2019 Jun 7.
  2. Bleisch B, Schuurmans MM, Klaghofer R, Benden C, Seiler A, Jenewein J.
    Health-related quality of life and stress-related post-transplant trajectories  of lung transplant recipients: a three-year follow-up of the Swiss Transplant  Cohort Study.
    Swiss Med Wkly. 2019 Feb 24;149(07-08).
  3. Hofmann P, Kohler M, Benden C, Schuurmans MM.
    Tobacco use after Lung Transplantation: A retrospective analysis of patient characteristics, smoking cessation interventions and cessation success rates.
    Transplantation. 2019 Feb 4.
  4. Sulser P, Lehmann K, Schuurmans MM, Weder W, Inci I.
    Early and late abdominal surgeries after lung transplantation: incidence and outcome.
    Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):727-732.
  5. Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M,  Binet I, Cogliatti S, Haralamvieva E, Koller M, The Swiss Transplant Cohort Study Stcs, Dietrich PY.
    Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
    Swiss Med Wkly. 2018 Mar 8;148:w14596.
  6. Robinson CA, Inci I, Naegeli M, Murer C, Schuurmans MM, Urosevic-Maiwald M, Schüpbach R, Weder W, Benden C.
    Extracorporeal photopheresis as second-line treatment therapy in life- threatening primary graft dysfunction following lung transplantation.
    Pediatr Transplant. 2018 May;22(3):e13145.
  7. Leibl M, Robinson C, Schuurmans MM.
    Comparison of diagnostic performance of rapid and standard polymerase chain reaction laboratory test for influenza and respiratory syncytial virus detection in nasopharyngeal swabs from symptomatic lung transplant  recipients.
    Infect Dis (Lond). 2018 Jun;50(6):476-478.
  8. Weber NT, Bonani M, Benden C, Schleich A, Fehr T, Mueller TF, Schuurmans MM.
    Evolution of lung and kidney allograft function in patients receiving kidney after lung transplantation.
    Clin Transplant. 2018 Feb;32(2).
  9. Cosgun T, Tomaszek S, Opitz I, Wilhelm M, Schuurmans MM, Weder W, Inci I.
    Single-center experience with intraoperative extracorporeal membrane oxygenation use in lung transplantation.
    Int J Artif Organs. 2017 Oct 9:0.
  10. Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C.
    Lung transplant recipients on long-term extracorporeal photopheresis.
    Clin Transplant. 2017 Jun 27. doi: 10.1111/ctr.13041.
  11. Robinson CA, Huber L, Murer C, Schuurmans M, Kohler M, Hofbauer G, Benden C.
    Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Swiss Med Wkly. 2017 May 10;147:w14429.
  12. Aigner F, Husmann M, Huber LC, Benden C, Schuurmans MM.
    Conservative management of distal leg necrosis in lung transplant recipients.
    J Tissue Viability. 2017 May;26(2):95-102.
  13. Heinrich H, Neuenschwander A, Russmann S, Misselwitz B, Benden C, Schuurmans MM.
    Prevalence of gastrointestinal dysmotility and complications detected by abdominal plain films after lung transplantation: a single-centre cohort study.
    BMJ Open Respir Res. 2016 Dec 23;3(1):e000162.
  14. Schmid FA, Inci I, Bürgi U, Hillinger S, Schneiter D, Opitz I, Huber LC, Isenring BD, Jungraithmayr W, Schuurmans MM, Weder W, Benden C.
    Favorable outcome of children and adolescents undergoing lung transplantation at a European adult center in the new era.
    Pediatr Pulmonol. 2016 Nov;51(11):1222-1228.
  15. Vetter D, Schuurmans MM, Benden C, Clavien PA, Nocito A.
    Long-term follow-up of lung transplant recipients supports non-operative treatment of uncomplicated diverticulitis.
    Clin Transplant. 2016 Oct;30(10):1264-1270.
  16. Niggli F, Huber LC, Benden C, Schuurmans MM.
    Human metapneumovirus in lung transplant recipients: characteristics and outcomes.
    Infect Dis (Lond). 2016 Jul 6:1-5. [Epub ahead of print].
  17. Hofmann P, Hombach M, Seifert B, Schuurmans MM, Bürgi U, Isenring B, Mueller NJ, Kohler M, Benden C, Huber LC.
    Isolation of Stenotrophomonas maltophilia in asymptomatic lung transplant recipients: effects of treatment on eradication and outcome.
    Clin Transplant. 2016 Aug;30(8):857-63.
  18. Franzen D, Diacon AH, Freitag L, Schubert PT, Wright CA, Schuurmans MM.
    Ultrathin bronchoscopy for solitary pulmonary lesions in a region endemic for tuberculosis: a randomised pilot trial.
    BMC Pulm Med. 2016 Apr 27;16(1):62.
  19. Schmid FA, Inci I, Bürgi U, Hillinger S, Schneiter D, Opitz I, Huber LC, Isenring BD, Jungraithmayr W, Schuurmans MM, Weder W, Benden C.
    Favorable outcome of children and adolescents undergoing lung transplantation at a European adult center in the new era.
    Pediatr Pulmonol. 2016 Jan 15. doi: 10.1002/ppul.23383. [Epub ahead of print].
  20. Seiler A, Jenewein J, Martin-Soelch C, Goetzmann L, Inci I, Weder W, Schuurmans MM, Benden C, Brucher A, Klaghofer R.
    Post-transplant outcome-clusters of psychological distress and health-related quality of life in lung transplant recipients.
    Swiss Med Wkly. 2015 Dec 28;145:w14236.
  21. Gerber SR, Seifert B, Inci I, Serra AL, Kohler M, Benden C, Hofbauer GF, Schuurmans MM.
    Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients.
    J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2451-7.
  22. Inci I, Schuurmans M, Ehrsam J, Schneiter D, Hillinger S, Jungraithmayr W, Benden C, Weder W.
    Lung transplantation for emphysema: impact of age on short- and long-term survival.
    Eur J Cardiothorac Surg. 2015 Jan 18. pii: ezu550.
  23. Wild J, Arrigo M, Isenring BD, Buergi U, Kurowski T, Schuurmans MM, Huber LC, Benden C.
    Coronary artery disease in lung transplant candidates: role of routine invasive assessment.
    Respiration. 2015;89(2):107-11.
  24. Schuurmans MM, Isenring BD, Jungo C, Serra A, Boeni J, Mueller NJ, Kohler M , Benden C
    Clinical features and outcomes of influenza infections in lung transplant recipients: A single season cohort study.
    Transpl Infect Dis. 2014 Jun;16(3):430-439.
  25. Inci I, Schuurmans MM, Kestenholz P, Schneiter D, Hillinger S, Opitz I, Boehler A, Weder W.
    Long-term outcomes of bilateral lobar lung transplantation.
    Eur J Cardiothorac Surg. 2012 Oct;43:1220-1225.
  26. Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A.
    Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.
    J Heart Lung Transplant. 2011 Jun;30(6):685-90.
  27. Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM.
    Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
    Int J Chron Obstruct Pulmon Dis. 2008;3(4):693-9.
  28. Stucki A, Stucki G, Cieza A, Schuurmans MM, Kostanjsek N, Ruof J.
    Content comparison of health-related quality of life instruments for COPD.
    Respir Med. 2007 Jun;101(6):1113-22.
  29. Horsch K, de Wet H, Schuurmans MM, Allie-Reid F, Cato AC, Cunningham J, Burrin JM, Hough FS, Hulley PA.
    Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
    Mol Endocrinol. 2007 Dec;21(12):2929-40.
  30. Schuurmans MM, Ellmann A, Bouma H, Diacon AH, Dyckmans K, Bolliger CT.
    Solitary pulmonary nodule evaluation with 99mTc-methoxy isobutyl isonitrile in a tuberculosis-endemic area.
    Eur Respir J. 2007 Dec;30(6):1090-5. Epub 2007 Sep 5.
  31. Stucki A, Cieza A, Schuurmans MM, Ustun B, Stucki G, Gradinger F, Partinen M.
    Content comparison of health-related quality of life instruments for obstructive sleep apnea.
    Sleep Med. 2008 Jan;9(2):199-206.
  32. Diacon AH, Schuurmans MM, Theron J, Brundyn K, Louw M, Wright CA, Bolliger CT.
    Transbronchial needle aspirates: how many passes per target site?
    Eur Respir J. 2007 Jan;29(1):112-6.
  33. Diacon AH, Schuurmans MM, Theron J, Brundyn K, Louw M, Wright CA, Bolliger CT.
    Transbronchial needle aspirates: comparison of two preparation methods.
    Chest. 2005 Jun;127(6):2015-8.
  34. Diacon AH, Schuurmans MM, Theron J, Louw M, Wright CA, Bolliger CT.
    Utility of rapid on-site evaluation of transbronchial needle aspirates.
    Respiration. 2005 Mar-Apr;72(2):182-8.
  35. Dieterle T, Schuurmans MM, Strobel W, Battegay EJ, Martina B.
    Moderate-to-severe blood pressure elevation at ED entry: hypertension or normotension?
    Am J Emerg Med. 2005 Jul;23(4):474-9.
  36. Schuurmans MM, Botha P, Steyn D, Richter DC, Bolliger CT.
    Time to spirometric and exercise response in 4-week oral corticosteroid trial for stable COPD patients.
    Swiss Med Wkly. 2005 Sep 17;135(37-38):562-8.
  37. Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT.
    Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Addiction. 2004;99:634-40.
  38. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT.
    Intrapleural streptokinase for empyema and complicated parapneumonic effusions.
    Am J Respir Crit Care Med. 2004;170:49-53.
  39. Diacon AH, Schuurmans MM, Theron J, Schubert PT, Wright CA, Bolliger CT.
    Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists.
    Respiration. 2004;71:519-22.
  40. Schneider-Yin X, Hergersberg M, Schuurmans MM, Gregor A, Minder EI.
    Mutation hotspots in the human porphobilinogen deaminase gene: recurrent mutations G111R and R173Q occurring at CpG motifs.
    J Inherit Metab Dis. 2004;27:625-31.
  41. Swart F, Schuurmans MM,Heydenreich JH, Pieper CH, Bolliger CT.
    Comparison of a new desktop spirometer (Spirospec) with a laboratory spirometer in a respiratory out-patient clinic.
    Respir Care 2003 Jun;48:591-5.
  42. Schuurmans MM, Michaud GC, Diacon AH, Bolliger CT.
    Use of an ultra-thin bronchoscope in the assessment of central airway obstruction.
    Chest 2003;124:735-9.
  43. Schneider-Yin X, Hergersberg M, Goldgar DE,, Rüfenacht, UB, Schuurmans MM, Puy H, Deybach JC, Minder EI.
    Ancestral Founder of Mutation W283X in the Porphobilinogen Deaminase Gene among Acute Intermittent Porphyria Patients.
    Hum Hered 2002; 54:69-81.
  44. Schuurmans MM, Schneider-Yin X, Rüfenacht U, Minder CE, Puy H, Deybach JC, Minder EI.
    Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Mol Med 2001; 7 (8):535-542.
  45. Schuurmans MM, Hoffmann F, Lindberg RL, Meyer UA.
    Zinc Mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in mouse model of acute hepatic porphyria.
    Hepatology 2001; 33(5):1217-22.
  46. Schwarz R, Schuurmans M, Seelig J, Kunnecke B.
    19F-MRI of perfluorononane as a novel contrast modality for gastrointestinal imaging.
    Magn Reson Med. 1999; 41(1):80-6.

Es sind nur Original-Publikationen mit expliziter Namensnennung (Schuurmans) in der Autorenliste aufgeführt. Weitere Publikationen, z. B. im Zusammenhang mit dem SysCLAD Consortium, sind nicht aufgeführt, obwohl Co-Autor (siehe Pubmed.gov).

Übersichtsarbeiten / Reviews

  1. Hofmann P, Benden C, Kohler M, Schuurmans MM.
    Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management.
    J Thorac Dis. 2018 Jul;10(7):4609-4618. doi: 10.21037/jtd.2018.07.16. Review. PubMed PMID: 30174913.
  2. Gruber D, Schuurmans MM.
    [Biomarkers of Smoking – Which Cut-Off Values Should be Used?].
    Praxis (Bern 1994). 2018 Jul;107(14):758-762. doi: 10.1024/1661-8157/a003026.
  3. Speck NE, Schuurmans MM, Benden C, Robinson CA, Huber LC.
    Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers.
    Respir Res. 2017 Aug 7;18(1):151. doi: 10.1186/s12931-017-0634-6.
  4. Hangartner N, Schuurmans MM, Murer C, Benden C, Huber LC.
    Therapeutic options for bronchiolitis obliterans syndrome after lung transplantation.
    Eurasian J Pulmonol 2016;18(2): 63-69. doi: 10.5152/ejp.2016.92486.
  5. Speck NE, Schuurmans MM, Murer C, Benden C, Huber LC.
    Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology.
    Respir Res. 2016 Jun 21;17(1):74.
  6. Schuurmans MM.
    [Electronic Cigarettes: Lifestyle Gadget or Smoking Cessation Aid?].
    Praxis (Bern 1994). 2015 Jul 1;104(14):733-7. doi: 10.1024/1661-8157/a002057.
  7. Huber LC, Bürgi U, Schuurmans MM, Benden C.
    [Non-cystic fibrosis bronchiectasis: diagnosis and treatment].
    Dtsch Med Wochenschr. 2014 Aug;139(34-35):1714-20.
  8. Schuurmans MM, Benden C, Huber LC.
    Managing Viral Respiratory Tract Infections in Lung Transplant Recipients.
    Eurasian J Pulmonol 2014;16:144-149.
  9. Huber LC, Isenring BD, Schuurmans MM.
    Diagnostik, Therapie und Prophylaxe von respiratorischen Viren bei lungentransplantierten Patienten.
    Praxis (Bern 1994) 2014; Apr 9;103(8):453-459.
  10. Schuurmans MM, Benden C, Inci I.
    Practical approach to early postoperative management of lung transplant recipients.
    Swiss Med Wkly. 2013;143:w13773.
  11. Schuurmans MM, Tini GM, Zuercher A, Hofer M, Benden C, Boehler A.
    Practical approach to emergencies in lung transplant recipients: how we do it.
    Respiration. 2012;84(2):163-75.
  12. Schuurmans MM, Burkhalter AK, Zellweger JP.
    Rauchstopp-Beratung für die Praxis. Evidenz-basierte Informationen und erfahrungsmedizinische Tipps.
    Schweiz Zeitschrift für Psychiatrie & Neurologie. 02.2009: 27-34.
  13. Schuurmans MM.
    [Diagnosing pulmonary tuberculosis].
    Ther Umsch. 2011 Jul;68(7):369-75. German.
  14. Schuurmans MM, Diacon AH, Bolliger CT.
    Functional evaluation before lung resection.
    Clin Chest Med 2002;23:159-172
  15. Meyer UA, Schuurmans MM, Lindberg RL.
    Acute porphyrias: pathogenesis of neurological manifestations.
    Semin Liver Dis. 1998;18(1):43-52.

Fallberichte

  1. Abela IA, Murer C, Schuurmans MM, Schmitt JW, Muller F, Imkamp F, Mueller NJ, Benden C.
    A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.
    Transpl Infect Dis. 2018 Feb;20(1).
  2. Schuurmans MM, Benden C, Moehrlen C, Gubler C, Wilhelm M, Weder W, Inci I.
    Esophagopericardial fistula, septic shock and intracranial hemorrhage with hydrocephalus after lung transplantation.
    Rev Port Pneumol (2006). 2017 May – Jun;23(3):156-159.
  3. Lewandowska DW, Schreiber PW, Schuurmans MM, Ruehe B, Zagordi O, Bayard C, Greiner M, Geissberger FD, Capaul R, Zbinden A, Böni J, Benden C, Mueller NJ, Trkola A, Huber M.
    Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection.
    PLoS One. 2017 May 23;12(5):e0177340.
  4. Schwarz EI, Vrugt B, Huber LC, Murer C, Schuurmans MM, Inci I, Benden C.
    Development of Allograft Cancer after Lung Transplantation: A Case Report.
    Ann Thorac Cardiovasc Surg. 2017 Mar 29.
  5. Lewandowska DW, Zagordi O, Zbinden A, Schuurmans MM, Schreiber P, Geissberger FD, Huder JB, Böni J, Benden C, Mueller NJ, Trkola A, Huber M.
    Unbiased metagenomic sequencing complements specific routine diagnostic methods and increases chances to detect rare viral strains.
    Diagn Microbiol Infect Dis. 2015 Oct;83(2):133-8.
  6. Schuurmans MM, Palheiros Marques M, Freitag L, Zinkernagel AS, Achermann Y.
    Biofilm Formation in a Permanent Tracheal Stent Implanted for Twenty-Five Years.
    Respiration. 2015;90(4):327-8. doi: 10.1159/000439312.
  7. Dalar L, Schuurmans MM, Eryüksel E, , Karasulu AL, Koşar F, Altın S.
    Early tracheal stenosis as a cause of extubation failure and prolonged ventilator dependency.
    Anaesth Intens Care. 2013 Jan;41(1):108-12.
  8. Tischler V, Schuurmans MM, Boehler A, Gaspert A.
    Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient.
    J Heart Lung Transplant. 2012 Sep;31(9):1037-40.
  9. van der Merwe E, Schuurmans MM, de Kock F, Siebert I, Wright C, Bolliger CT.
    Bloodstained pleural effusion in a 38-year-old non-smoking female.
    Respiration. 2005;72:101-4.
  10. Schuurmans MM, Davel S, Diacon AH.
    Non-responding “tension pneumothorax” following stab wounds.
    Respiration 2003; 70:100.
  11. Diacon AH, Schuurmans MM, Colesky FJ, Bolliger CT.
    Paraneoplastic bilateral proptosis in a case of non-small cell lung cancer.
    Chest 2003;123:627-629.
  12. Schuurmans MM, Alheit B, MacGregor L, von Ullmenstein D, Foden AP.
    Sudden onset of dyspnoea and chest pain in a 39-year old woman. Eye Catcher.
    Respiration 2002;69:268.

Buchkapitel

  1. Schuurmans MM, Bolliger CT, Boehler A (2013).
    Assessment for anaesthesia/surgery.
    In: ERS Handbook of Respiratory Medicine. 2nd Edition.
    Palange P, Simonds A. (eds.) pp. 174-177. European Respiratory Society: Sheffield.
  2. Schuurmans MM, Bolliger CT, Boehler A (2010).
    Assessment for anaesthesia/surgery.
    In: Chapter 6: Lung Ingury and Respiratory Failure. ERS Handbook of Respiratory Medicine. 1st Edition.
    Palange P, Simonds A (eds) pp. 156-159, European Respiratory Society: Sheffield.
  3. Schuurmans MM, Bolliger CT (2004).
    Silicone Airway Stents.
    In: Interventional Pulmonary Medicine.
    Beamis JF Jr, Mathur PN, Mehta AC (eds.), Marcel Dekker: New York.
  4. Schuurmans MM, Meyer UA (1999).
    Akute hepatische Porphyrie.
    In: Internistische Notfälle.
    Gyr NE, Schoenenberger RA, Haefeli WE (eds.), pp. 137-139, Thieme: Stuttgart.
  5. Schuurmans M (1985).
    Frisbee – Geschichte und Aerodynamik.
    In: Schweizer Jugend forscht, Jahrbuch, pp. 161-167, Bern.

Andere Publikationen

  1. Schuurmans MM.
    [COPD management: what is essential?].
    Praxis (Bern 1994). 2015 Aug 19;104(17):879-80. doi: 10.1024/1661-8157/a002120. German.
  2. Schuurmans MM, Barben J.
    Stellungname zu E-Zigaretten.
    Schweizerische Aerztezeitung 2014;95:16-17.
  3. Barben J, Schuurmans M, Karrer W, Schmid T, Kaelin RM.
    Die E-Zigarette: was erklären wir unseren Patienten?
    Schweiz Med Forum 2014; 14 (15): 317–320.
  4. Sudano I, Schuurmans MM.
    Raucherentwöhnung: Eine Chance für COPD-Patienten.
    Hausarzt Praxis 2012, 16-17:10-13.
  5. Schuurmans MM, Zellweger JP.
    [Smoking cessation in medical practice—new possibilities?].
    Rev Med Suisse. 2012 Jan 25;8(325):235-6. Review. German.
  6. Cornuz J, Jacot-Sadowski I , Humair JP , Clair C , Schuurmans M ,Zellweger JP Cornuz J.
    Tabakentwöhnung Update 2011. Teil 1.
    Schweiz Med Forum 2011, Nr. 09/11: 156-159;
  7. Cornuz J, Jacot-Sadowski I , Humair JP , Clair C , Schuurmans M ,Zellweger JP Cornuz J.
    Tabakentwöhnung Update 2011. Teil 2.
    Schweiz Med Forum 2011, Nr. 10/11:172-176.
  8. Schuurmans MM, Bussinger C, Müller V, Burkhalter AK, Bolliger CT.
    [Smoking cessation training for physicians and other health professionals in Switzerland].
    Ther Umsch. 2010 Aug;67(8):409-14.
  9. Cornuz J, Humair J-P, Zoller M, Schuurmans M, Zellweger J-P.
    Remboursement des traitements médicamenteux du sevrage tabagique: une priorité pour la Suisse.
    Schweiz Ärztezeitung. 2008;2008(30):1297-1299
  10. Schuurmans MM, Bolliger CT.
    Smoking cessation strategies for real-life situations?
    Swiss Med Wkly 2003;133:29-30.
  11. Schuurmans M, Solèr M.
    COPD-Therapie: Bronchodilatatoren und Steroide.
    Therapiewoche 2001, 17,1:28-32.
  12. Schuurmans M.
    Cholera in Maputo, Mozambique-A doctor’s view.
    Moustiques (MSF) 2000;50:6-7.
  13. Schuurmans M.
    Flight of the Frisbee.
    New Scientist 1990; 1727:37-40.

Deutsch

Englisch

Französisch

Portugiesisch

  • Publikationen

    Originalarbeiten

    1. Jungo C, Russmann S, Benden C, Schuurmans MM.
      Use of oseltamivir in lung transplant recipients with suspected or proven influenza infection: a 1-year observational study of outcomes and safety.
      Antivir Ther. 2019 Jun 7.
    2. Bleisch B, Schuurmans MM, Klaghofer R, Benden C, Seiler A, Jenewein J.
      Health-related quality of life and stress-related post-transplant trajectories  of lung transplant recipients: a three-year follow-up of the Swiss Transplant  Cohort Study.
      Swiss Med Wkly. 2019 Feb 24;149(07-08).
    3. Hofmann P, Kohler M, Benden C, Schuurmans MM.
      Tobacco use after Lung Transplantation: A retrospective analysis of patient characteristics, smoking cessation interventions and cessation success rates.
      Transplantation. 2019 Feb 4.
    4. Sulser P, Lehmann K, Schuurmans MM, Weder W, Inci I.
      Early and late abdominal surgeries after lung transplantation: incidence and outcome.
      Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):727-732.
    5. Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M,  Binet I, Cogliatti S, Haralamvieva E, Koller M, The Swiss Transplant Cohort Study Stcs, Dietrich PY.
      Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
      Swiss Med Wkly. 2018 Mar 8;148:w14596.
    6. Robinson CA, Inci I, Naegeli M, Murer C, Schuurmans MM, Urosevic-Maiwald M, Schüpbach R, Weder W, Benden C.
      Extracorporeal photopheresis as second-line treatment therapy in life- threatening primary graft dysfunction following lung transplantation.
      Pediatr Transplant. 2018 May;22(3):e13145.
    7. Leibl M, Robinson C, Schuurmans MM.
      Comparison of diagnostic performance of rapid and standard polymerase chain reaction laboratory test for influenza and respiratory syncytial virus detection in nasopharyngeal swabs from symptomatic lung transplant  recipients.
      Infect Dis (Lond). 2018 Jun;50(6):476-478.
    8. Weber NT, Bonani M, Benden C, Schleich A, Fehr T, Mueller TF, Schuurmans MM.
      Evolution of lung and kidney allograft function in patients receiving kidney after lung transplantation.
      Clin Transplant. 2018 Feb;32(2).
    9. Cosgun T, Tomaszek S, Opitz I, Wilhelm M, Schuurmans MM, Weder W, Inci I.
      Single-center experience with intraoperative extracorporeal membrane oxygenation use in lung transplantation.
      Int J Artif Organs. 2017 Oct 9:0.
    10. Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C.
      Lung transplant recipients on long-term extracorporeal photopheresis.
      Clin Transplant. 2017 Jun 27. doi: 10.1111/ctr.13041.
    11. Robinson CA, Huber L, Murer C, Schuurmans M, Kohler M, Hofbauer G, Benden C.
      Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
      Swiss Med Wkly. 2017 May 10;147:w14429.
    12. Aigner F, Husmann M, Huber LC, Benden C, Schuurmans MM.
      Conservative management of distal leg necrosis in lung transplant recipients.
      J Tissue Viability. 2017 May;26(2):95-102.
    13. Heinrich H, Neuenschwander A, Russmann S, Misselwitz B, Benden C, Schuurmans MM.
      Prevalence of gastrointestinal dysmotility and complications detected by abdominal plain films after lung transplantation: a single-centre cohort study.
      BMJ Open Respir Res. 2016 Dec 23;3(1):e000162.
    14. Schmid FA, Inci I, Bürgi U, Hillinger S, Schneiter D, Opitz I, Huber LC, Isenring BD, Jungraithmayr W, Schuurmans MM, Weder W, Benden C.
      Favorable outcome of children and adolescents undergoing lung transplantation at a European adult center in the new era.
      Pediatr Pulmonol. 2016 Nov;51(11):1222-1228.
    15. Vetter D, Schuurmans MM, Benden C, Clavien PA, Nocito A.
      Long-term follow-up of lung transplant recipients supports non-operative treatment of uncomplicated diverticulitis.
      Clin Transplant. 2016 Oct;30(10):1264-1270.
    16. Niggli F, Huber LC, Benden C, Schuurmans MM.
      Human metapneumovirus in lung transplant recipients: characteristics and outcomes.
      Infect Dis (Lond). 2016 Jul 6:1-5. [Epub ahead of print].
    17. Hofmann P, Hombach M, Seifert B, Schuurmans MM, Bürgi U, Isenring B, Mueller NJ, Kohler M, Benden C, Huber LC.
      Isolation of Stenotrophomonas maltophilia in asymptomatic lung transplant recipients: effects of treatment on eradication and outcome.
      Clin Transplant. 2016 Aug;30(8):857-63.
    18. Franzen D, Diacon AH, Freitag L, Schubert PT, Wright CA, Schuurmans MM.
      Ultrathin bronchoscopy for solitary pulmonary lesions in a region endemic for tuberculosis: a randomised pilot trial.
      BMC Pulm Med. 2016 Apr 27;16(1):62.
    19. Schmid FA, Inci I, Bürgi U, Hillinger S, Schneiter D, Opitz I, Huber LC, Isenring BD, Jungraithmayr W, Schuurmans MM, Weder W, Benden C.
      Favorable outcome of children and adolescents undergoing lung transplantation at a European adult center in the new era.
      Pediatr Pulmonol. 2016 Jan 15. doi: 10.1002/ppul.23383. [Epub ahead of print].
    20. Seiler A, Jenewein J, Martin-Soelch C, Goetzmann L, Inci I, Weder W, Schuurmans MM, Benden C, Brucher A, Klaghofer R.
      Post-transplant outcome-clusters of psychological distress and health-related quality of life in lung transplant recipients.
      Swiss Med Wkly. 2015 Dec 28;145:w14236.
    21. Gerber SR, Seifert B, Inci I, Serra AL, Kohler M, Benden C, Hofbauer GF, Schuurmans MM.
      Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients.
      J Eur Acad Dermatol Venereol. 2015 Dec;29(12):2451-7.
    22. Inci I, Schuurmans M, Ehrsam J, Schneiter D, Hillinger S, Jungraithmayr W, Benden C, Weder W.
      Lung transplantation for emphysema: impact of age on short- and long-term survival.
      Eur J Cardiothorac Surg. 2015 Jan 18. pii: ezu550.
    23. Wild J, Arrigo M, Isenring BD, Buergi U, Kurowski T, Schuurmans MM, Huber LC, Benden C.
      Coronary artery disease in lung transplant candidates: role of routine invasive assessment.
      Respiration. 2015;89(2):107-11.
    24. Schuurmans MM, Isenring BD, Jungo C, Serra A, Boeni J, Mueller NJ, Kohler M , Benden C
      Clinical features and outcomes of influenza infections in lung transplant recipients: A single season cohort study.
      Transpl Infect Dis. 2014 Jun;16(3):430-439.
    25. Inci I, Schuurmans MM, Kestenholz P, Schneiter D, Hillinger S, Opitz I, Boehler A, Weder W.
      Long-term outcomes of bilateral lobar lung transplantation.
      Eur J Cardiothorac Surg. 2012 Oct;43:1220-1225.
    26. Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A.
      Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.
      J Heart Lung Transplant. 2011 Jun;30(6):685-90.
    27. Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM.
      Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
      Int J Chron Obstruct Pulmon Dis. 2008;3(4):693-9.
    28. Stucki A, Stucki G, Cieza A, Schuurmans MM, Kostanjsek N, Ruof J.
      Content comparison of health-related quality of life instruments for COPD.
      Respir Med. 2007 Jun;101(6):1113-22.
    29. Horsch K, de Wet H, Schuurmans MM, Allie-Reid F, Cato AC, Cunningham J, Burrin JM, Hough FS, Hulley PA.
      Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation.
      Mol Endocrinol. 2007 Dec;21(12):2929-40.
    30. Schuurmans MM, Ellmann A, Bouma H, Diacon AH, Dyckmans K, Bolliger CT.
      Solitary pulmonary nodule evaluation with 99mTc-methoxy isobutyl isonitrile in a tuberculosis-endemic area.
      Eur Respir J. 2007 Dec;30(6):1090-5. Epub 2007 Sep 5.
    31. Stucki A, Cieza A, Schuurmans MM, Ustun B, Stucki G, Gradinger F, Partinen M.
      Content comparison of health-related quality of life instruments for obstructive sleep apnea.
      Sleep Med. 2008 Jan;9(2):199-206.
    32. Diacon AH, Schuurmans MM, Theron J, Brundyn K, Louw M, Wright CA, Bolliger CT.
      Transbronchial needle aspirates: how many passes per target site?
      Eur Respir J. 2007 Jan;29(1):112-6.
    33. Diacon AH, Schuurmans MM, Theron J, Brundyn K, Louw M, Wright CA, Bolliger CT.
      Transbronchial needle aspirates: comparison of two preparation methods.
      Chest. 2005 Jun;127(6):2015-8.
    34. Diacon AH, Schuurmans MM, Theron J, Louw M, Wright CA, Bolliger CT.
      Utility of rapid on-site evaluation of transbronchial needle aspirates.
      Respiration. 2005 Mar-Apr;72(2):182-8.
    35. Dieterle T, Schuurmans MM, Strobel W, Battegay EJ, Martina B.
      Moderate-to-severe blood pressure elevation at ED entry: hypertension or normotension?
      Am J Emerg Med. 2005 Jul;23(4):474-9.
    36. Schuurmans MM, Botha P, Steyn D, Richter DC, Bolliger CT.
      Time to spirometric and exercise response in 4-week oral corticosteroid trial for stable COPD patients.
      Swiss Med Wkly. 2005 Sep 17;135(37-38):562-8.
    37. Schuurmans MM, Diacon AH, van Biljon X, Bolliger CT.
      Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
      Addiction. 2004;99:634-40.
    38. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT.
      Intrapleural streptokinase for empyema and complicated parapneumonic effusions.
      Am J Respir Crit Care Med. 2004;170:49-53.
    39. Diacon AH, Schuurmans MM, Theron J, Schubert PT, Wright CA, Bolliger CT.
      Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists.
      Respiration. 2004;71:519-22.
    40. Schneider-Yin X, Hergersberg M, Schuurmans MM, Gregor A, Minder EI.
      Mutation hotspots in the human porphobilinogen deaminase gene: recurrent mutations G111R and R173Q occurring at CpG motifs.
      J Inherit Metab Dis. 2004;27:625-31.
    41. Swart F, Schuurmans MM,Heydenreich JH, Pieper CH, Bolliger CT.
      Comparison of a new desktop spirometer (Spirospec) with a laboratory spirometer in a respiratory out-patient clinic.
      Respir Care 2003 Jun;48:591-5.
    42. Schuurmans MM, Michaud GC, Diacon AH, Bolliger CT.
      Use of an ultra-thin bronchoscope in the assessment of central airway obstruction.
      Chest 2003;124:735-9.
    43. Schneider-Yin X, Hergersberg M, Goldgar DE,, Rüfenacht, UB, Schuurmans MM, Puy H, Deybach JC, Minder EI.
      Ancestral Founder of Mutation W283X in the Porphobilinogen Deaminase Gene among Acute Intermittent Porphyria Patients.
      Hum Hered 2002; 54:69-81.
    44. Schuurmans MM, Schneider-Yin X, Rüfenacht U, Minder CE, Puy H, Deybach JC, Minder EI.
      Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
      Mol Med 2001; 7 (8):535-542.
    45. Schuurmans MM, Hoffmann F, Lindberg RL, Meyer UA.
      Zinc Mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in mouse model of acute hepatic porphyria.
      Hepatology 2001; 33(5):1217-22.
    46. Schwarz R, Schuurmans M, Seelig J, Kunnecke B.
      19F-MRI of perfluorononane as a novel contrast modality for gastrointestinal imaging.
      Magn Reson Med. 1999; 41(1):80-6.

    Es sind nur Original-Publikationen mit expliziter Namensnennung (Schuurmans) in der Autorenliste aufgeführt. Weitere Publikationen, z. B. im Zusammenhang mit dem SysCLAD Consortium, sind nicht aufgeführt, obwohl Co-Autor (siehe Pubmed.gov).

    Übersichtsarbeiten / Reviews

    1. Hofmann P, Benden C, Kohler M, Schuurmans MM.
      Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management.
      J Thorac Dis. 2018 Jul;10(7):4609-4618. doi: 10.21037/jtd.2018.07.16. Review. PubMed PMID: 30174913.
    2. Gruber D, Schuurmans MM.
      [Biomarkers of Smoking – Which Cut-Off Values Should be Used?].
      Praxis (Bern 1994). 2018 Jul;107(14):758-762. doi: 10.1024/1661-8157/a003026.
    3. Speck NE, Schuurmans MM, Benden C, Robinson CA, Huber LC.
      Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers.
      Respir Res. 2017 Aug 7;18(1):151. doi: 10.1186/s12931-017-0634-6.
    4. Hangartner N, Schuurmans MM, Murer C, Benden C, Huber LC.
      Therapeutic options for bronchiolitis obliterans syndrome after lung transplantation.
      Eurasian J Pulmonol 2016;18(2): 63-69. doi: 10.5152/ejp.2016.92486.
    5. Speck NE, Schuurmans MM, Murer C, Benden C, Huber LC.
      Diagnostic value of plasma and bronchoalveolar lavage samples in acute lung allograft rejection: differential cytology.
      Respir Res. 2016 Jun 21;17(1):74.
    6. Schuurmans MM.
      [Electronic Cigarettes: Lifestyle Gadget or Smoking Cessation Aid?].
      Praxis (Bern 1994). 2015 Jul 1;104(14):733-7. doi: 10.1024/1661-8157/a002057.
    7. Huber LC, Bürgi U, Schuurmans MM, Benden C.
      [Non-cystic fibrosis bronchiectasis: diagnosis and treatment].
      Dtsch Med Wochenschr. 2014 Aug;139(34-35):1714-20.
    8. Schuurmans MM, Benden C, Huber LC.
      Managing Viral Respiratory Tract Infections in Lung Transplant Recipients.
      Eurasian J Pulmonol 2014;16:144-149.
    9. Huber LC, Isenring BD, Schuurmans MM.
      Diagnostik, Therapie und Prophylaxe von respiratorischen Viren bei lungentransplantierten Patienten.
      Praxis (Bern 1994) 2014; Apr 9;103(8):453-459.
    10. Schuurmans MM, Benden C, Inci I.
      Practical approach to early postoperative management of lung transplant recipients.
      Swiss Med Wkly. 2013;143:w13773.
    11. Schuurmans MM, Tini GM, Zuercher A, Hofer M, Benden C, Boehler A.
      Practical approach to emergencies in lung transplant recipients: how we do it.
      Respiration. 2012;84(2):163-75.
    12. Schuurmans MM, Burkhalter AK, Zellweger JP.
      Rauchstopp-Beratung für die Praxis. Evidenz-basierte Informationen und erfahrungsmedizinische Tipps.
      Schweiz Zeitschrift für Psychiatrie & Neurologie. 02.2009: 27-34.
    13. Schuurmans MM.
      [Diagnosing pulmonary tuberculosis].
      Ther Umsch. 2011 Jul;68(7):369-75. German.
    14. Schuurmans MM, Diacon AH, Bolliger CT.
      Functional evaluation before lung resection.
      Clin Chest Med 2002;23:159-172
    15. Meyer UA, Schuurmans MM, Lindberg RL.
      Acute porphyrias: pathogenesis of neurological manifestations.
      Semin Liver Dis. 1998;18(1):43-52.

    Fallberichte

    1. Abela IA, Murer C, Schuurmans MM, Schmitt JW, Muller F, Imkamp F, Mueller NJ, Benden C.
      A cluster of scedosporiosis in lung transplant candidates and recipients: The Zurich experience and review of the literature.
      Transpl Infect Dis. 2018 Feb;20(1).
    2. Schuurmans MM, Benden C, Moehrlen C, Gubler C, Wilhelm M, Weder W, Inci I.
      Esophagopericardial fistula, septic shock and intracranial hemorrhage with hydrocephalus after lung transplantation.
      Rev Port Pneumol (2006). 2017 May – Jun;23(3):156-159.
    3. Lewandowska DW, Schreiber PW, Schuurmans MM, Ruehe B, Zagordi O, Bayard C, Greiner M, Geissberger FD, Capaul R, Zbinden A, Böni J, Benden C, Mueller NJ, Trkola A, Huber M.
      Metagenomic sequencing complements routine diagnostics in identifying viral pathogens in lung transplant recipients with unknown etiology of respiratory infection.
      PLoS One. 2017 May 23;12(5):e0177340.
    4. Schwarz EI, Vrugt B, Huber LC, Murer C, Schuurmans MM, Inci I, Benden C.
      Development of Allograft Cancer after Lung Transplantation: A Case Report.
      Ann Thorac Cardiovasc Surg. 2017 Mar 29.
    5. Lewandowska DW, Zagordi O, Zbinden A, Schuurmans MM, Schreiber P, Geissberger FD, Huder JB, Böni J, Benden C, Mueller NJ, Trkola A, Huber M.
      Unbiased metagenomic sequencing complements specific routine diagnostic methods and increases chances to detect rare viral strains.
      Diagn Microbiol Infect Dis. 2015 Oct;83(2):133-8.
    6. Schuurmans MM, Palheiros Marques M, Freitag L, Zinkernagel AS, Achermann Y.
      Biofilm Formation in a Permanent Tracheal Stent Implanted for Twenty-Five Years.
      Respiration. 2015;90(4):327-8. doi: 10.1159/000439312.
    7. Dalar L, Schuurmans MM, Eryüksel E, , Karasulu AL, Koşar F, Altın S.
      Early tracheal stenosis as a cause of extubation failure and prolonged ventilator dependency.
      Anaesth Intens Care. 2013 Jan;41(1):108-12.
    8. Tischler V, Schuurmans MM, Boehler A, Gaspert A.
      Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient.
      J Heart Lung Transplant. 2012 Sep;31(9):1037-40.
    9. van der Merwe E, Schuurmans MM, de Kock F, Siebert I, Wright C, Bolliger CT.
      Bloodstained pleural effusion in a 38-year-old non-smoking female.
      Respiration. 2005;72:101-4.
    10. Schuurmans MM, Davel S, Diacon AH.
      Non-responding “tension pneumothorax” following stab wounds.
      Respiration 2003; 70:100.
    11. Diacon AH, Schuurmans MM, Colesky FJ, Bolliger CT.
      Paraneoplastic bilateral proptosis in a case of non-small cell lung cancer.
      Chest 2003;123:627-629.
    12. Schuurmans MM, Alheit B, MacGregor L, von Ullmenstein D, Foden AP.
      Sudden onset of dyspnoea and chest pain in a 39-year old woman. Eye Catcher.
      Respiration 2002;69:268.

    Buchkapitel

    1. Schuurmans MM, Bolliger CT, Boehler A (2013).
      Assessment for anaesthesia/surgery.
      In: ERS Handbook of Respiratory Medicine. 2nd Edition.
      Palange P, Simonds A. (eds.) pp. 174-177. European Respiratory Society: Sheffield.
    2. Schuurmans MM, Bolliger CT, Boehler A (2010).
      Assessment for anaesthesia/surgery.
      In: Chapter 6: Lung Ingury and Respiratory Failure. ERS Handbook of Respiratory Medicine. 1st Edition.
      Palange P, Simonds A (eds) pp. 156-159, European Respiratory Society: Sheffield.
    3. Schuurmans MM, Bolliger CT (2004).
      Silicone Airway Stents.
      In: Interventional Pulmonary Medicine.
      Beamis JF Jr, Mathur PN, Mehta AC (eds.), Marcel Dekker: New York.
    4. Schuurmans MM, Meyer UA (1999).
      Akute hepatische Porphyrie.
      In: Internistische Notfälle.
      Gyr NE, Schoenenberger RA, Haefeli WE (eds.), pp. 137-139, Thieme: Stuttgart.
    5. Schuurmans M (1985).
      Frisbee – Geschichte und Aerodynamik.
      In: Schweizer Jugend forscht, Jahrbuch, pp. 161-167, Bern.

    Andere Publikationen

    1. Schuurmans MM.
      [COPD management: what is essential?].
      Praxis (Bern 1994). 2015 Aug 19;104(17):879-80. doi: 10.1024/1661-8157/a002120. German.
    2. Schuurmans MM, Barben J.
      Stellungname zu E-Zigaretten.
      Schweizerische Aerztezeitung 2014;95:16-17.
    3. Barben J, Schuurmans M, Karrer W, Schmid T, Kaelin RM.
      Die E-Zigarette: was erklären wir unseren Patienten?
      Schweiz Med Forum 2014; 14 (15): 317–320.
    4. Sudano I, Schuurmans MM.
      Raucherentwöhnung: Eine Chance für COPD-Patienten.
      Hausarzt Praxis 2012, 16-17:10-13.
    5. Schuurmans MM, Zellweger JP.
      [Smoking cessation in medical practice—new possibilities?].
      Rev Med Suisse. 2012 Jan 25;8(325):235-6. Review. German.
    6. Cornuz J, Jacot-Sadowski I , Humair JP , Clair C , Schuurmans M ,Zellweger JP Cornuz J.
      Tabakentwöhnung Update 2011. Teil 1.
      Schweiz Med Forum 2011, Nr. 09/11: 156-159;
    7. Cornuz J, Jacot-Sadowski I , Humair JP , Clair C , Schuurmans M ,Zellweger JP Cornuz J.
      Tabakentwöhnung Update 2011. Teil 2.
      Schweiz Med Forum 2011, Nr. 10/11:172-176.
    8. Schuurmans MM, Bussinger C, Müller V, Burkhalter AK, Bolliger CT.
      [Smoking cessation training for physicians and other health professionals in Switzerland].
      Ther Umsch. 2010 Aug;67(8):409-14.
    9. Cornuz J, Humair J-P, Zoller M, Schuurmans M, Zellweger J-P.
      Remboursement des traitements médicamenteux du sevrage tabagique: une priorité pour la Suisse.
      Schweiz Ärztezeitung. 2008;2008(30):1297-1299
    10. Schuurmans MM, Bolliger CT.
      Smoking cessation strategies for real-life situations?
      Swiss Med Wkly 2003;133:29-30.
    11. Schuurmans M, Solèr M.
      COPD-Therapie: Bronchodilatatoren und Steroide.
      Therapiewoche 2001, 17,1:28-32.
    12. Schuurmans M.
      Cholera in Maputo, Mozambique-A doctor’s view.
      Moustiques (MSF) 2000;50:6-7.
    13. Schuurmans M.
      Flight of the Frisbee.
      New Scientist 1990; 1727:37-40.
  • Sprachen

    Deutsch

    Englisch

    Französisch

    Portugiesisch